These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 9462899

  • 1. Programming of the hypothalamo-pituitary-adrenal axis and the fetal origins of adult disease hypothesis.
    Clark PM.
    Eur J Pediatr; 1998 Jan; 157 Suppl 1():S7-10. PubMed ID: 9462899
    [Abstract] [Full Text] [Related]

  • 2. Glucocorticoid excess and the developmental origins of disease: two decades of testing the hypothesis--2012 Curt Richter Award Winner.
    Reynolds RM.
    Psychoneuroendocrinology; 2013 Jan; 38(1):1-11. PubMed ID: 22998948
    [Abstract] [Full Text] [Related]

  • 3. Fetal programming of hypothalamic-pituitary-adrenal (HPA) axis function and behavior by synthetic glucocorticoids.
    Kapoor A, Petropoulos S, Matthews SG.
    Brain Res Rev; 2008 Mar; 57(2):586-95. PubMed ID: 17716742
    [Abstract] [Full Text] [Related]

  • 4. Fetal programming of the hypothalamic-pituitary-adrenal (HPA) axis: low birth weight and central HPA regulation.
    Ward AM, Syddall HE, Wood PJ, Chrousos GP, Phillips DI.
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1227-33. PubMed ID: 15001615
    [Abstract] [Full Text] [Related]

  • 5. Glucocorticoids, feto-placental 11 beta-hydroxysteroid dehydrogenase type 2, and the early life origins of adult disease.
    Seckl JR.
    Steroids; 1997 Jan; 62(1):89-94. PubMed ID: 9029721
    [Abstract] [Full Text] [Related]

  • 6. Impact of maternal steroids during pregnancy.
    Reynolds RM.
    Ann Endocrinol (Paris); 2016 Dec; 77(6):677-679. PubMed ID: 27646492
    [Abstract] [Full Text] [Related]

  • 7. Glucocorticoids, 11beta-hydroxysteroid dehydrogenase, and fetal programming.
    Seckl JR, Cleasby M, Nyirenda MJ.
    Kidney Int; 2000 Apr; 57(4):1412-7. PubMed ID: 10760076
    [Abstract] [Full Text] [Related]

  • 8. Impact of maternal undernutrition during the periconceptional period, fetal number, and fetal sex on the development of the hypothalamo-pituitary adrenal axis in sheep during late gestation.
    Edwards LJ, McMillen IC.
    Biol Reprod; 2002 May; 66(5):1562-9. PubMed ID: 11967224
    [Abstract] [Full Text] [Related]

  • 9. Prenatal xenobiotic exposure and intrauterine hypothalamus-pituitary-adrenal axis programming alteration.
    Zhang C, Xu D, Luo H, Lu J, Liu L, Ping J, Wang H.
    Toxicology; 2014 Nov 05; 325():74-84. PubMed ID: 25194749
    [Abstract] [Full Text] [Related]

  • 10. The fetal placental hypothalamic-pituitary-adrenal (HPA) axis, parturition and post natal health.
    Challis JR, Sloboda D, Matthews SG, Holloway A, Alfaidy N, Patel FA, Whittle W, Fraser M, Moss TJ, Newnham J.
    Mol Cell Endocrinol; 2001 Dec 20; 185(1-2):135-44. PubMed ID: 11738803
    [Abstract] [Full Text] [Related]

  • 11. Effects of repeated maternal betamethasone administration on growth and hypothalamic-pituitary-adrenal function of the ovine fetus at term.
    Sloboda DM, Newnham JP, Challis JR.
    J Endocrinol; 2000 Apr 20; 165(1):79-91. PubMed ID: 10750038
    [Abstract] [Full Text] [Related]

  • 12. Sex differences in early-life programming of the hypothalamic-pituitary-adrenal axis in humans suggest increased vulnerability in females: a systematic review.
    Carpenter T, Grecian SM, Reynolds RM.
    J Dev Orig Health Dis; 2017 Apr 20; 8(2):244-255. PubMed ID: 28103963
    [Abstract] [Full Text] [Related]

  • 13. Nicotine-induced over-exposure to maternal glucocorticoid and activated glucocorticoid metabolism causes hypothalamic-pituitary-adrenal axis-associated neuroendocrine metabolic alterations in fetal rats.
    Xu D, Liang G, Yan YE, He WW, Liu YS, Chen LB, Magdalou J, Wang H.
    Toxicol Lett; 2012 Mar 25; 209(3):282-90. PubMed ID: 22265867
    [Abstract] [Full Text] [Related]

  • 14. Fetal hypothalamic-pituitary adrenal (HPA) development and activation as a determinant of the timing of birth, and of postnatal disease.
    Challis J, Sloboda D, Matthews S, Holloway A, Alfaidy N, Howe D, Fraser M, Newnham J.
    Endocr Res; 2000 Nov 25; 26(4):489-504. PubMed ID: 11196419
    [Abstract] [Full Text] [Related]

  • 15. Glucocorticoid programming of pituitary-adrenal function: mechanisms and physiological consequences.
    O'Regan D, Welberg LL, Holmes MC, Seckl JR.
    Semin Neonatol; 2001 Aug 25; 6(4):319-29. PubMed ID: 11972433
    [Abstract] [Full Text] [Related]

  • 16. Corticosteroid-mediated programming and the pathogenesis of obesity and diabetes.
    Reynolds RM.
    J Steroid Biochem Mol Biol; 2010 Oct 25; 122(1-3):3-9. PubMed ID: 20117209
    [Abstract] [Full Text] [Related]

  • 17. The Hypothalamic-Pituitary-Adrenal Axis and the Fetus.
    Morsi A, DeFranco D, Witchel SF.
    Horm Res Paediatr; 2018 Oct 25; 89(5):380-387. PubMed ID: 29874660
    [Abstract] [Full Text] [Related]

  • 18. Fetal programming of hypothalamo-pituitary-adrenal function: prenatal stress and glucocorticoids.
    Kapoor A, Dunn E, Kostaki A, Andrews MH, Matthews SG.
    J Physiol; 2006 Apr 01; 572(Pt 1):31-44. PubMed ID: 16469780
    [Abstract] [Full Text] [Related]

  • 19. Epigenetic mechanisms of perinatal programming of hypothalamic-pituitary-adrenal function and health.
    Meaney MJ, Szyf M, Seckl JR.
    Trends Mol Med; 2007 Jul 01; 13(7):269-77. PubMed ID: 17544850
    [Abstract] [Full Text] [Related]

  • 20. Early-life glucocorticoid exposure: the hypothalamic-pituitary-adrenal axis, placental function, and long-term disease risk.
    Braun T, Challis JR, Newnham JP, Sloboda DM.
    Endocr Rev; 2013 Dec 01; 34(6):885-916. PubMed ID: 23970762
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.